Court Approves $250 Million Sale of CVS Unit Omnicare
A U.S. court approved the $250 million sale of CVS unit Omnicare to GenieRx. The transaction includes cash and is expected to close by the end of this year.
Xurve View
Insights:
Xurve View
CVS HEALTH CORP unit Omnicare won court approval on Wednesday evening for a $250 million sale to GenieRx. The transaction follows a September bankruptcy filing intended to resolve litigation-related liabilities. Omnicare provides pharmacy services to the long-term care market.